These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38527461)

  • 1. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
    Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
    Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin-A injections improve sexual function?
    Topcuoglu M; Karaburun MC; İbiş A; Gokce Mİ; Süer E; Gülpinar O
    Neurourol Urodyn; 2023 Mar; 42(3):607-614. PubMed ID: 36708358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
    Jhang JF; Yu WR; Kuo HC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
    Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
    J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Botulinum Toxin Type A Injections Improve Symptoms Associated With Interstitial Cystitis/Bladder Pain Syndrome in Women: A Retrospective Cohort Study.
    Wang Y; Zheng J; Li Z; Jiang Y; Yu J; Li S; Chen X
    Urology; 2024 Jul; 189():27-33. PubMed ID: 38710455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection location does not impact botulinum toxin A efficacy in interstitial cystitis/bladder pain syndrome patients.
    Evans RJ; Overholt T; Colaco M; Walker SJ
    Can J Urol; 2020 Feb; 27(1):10125-10129. PubMed ID: 32065870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
    Jiang YH; Jhang JF; Lee CL; Kuo HC
    Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
    Chung SD; Kuo YC; Kuo HC
    Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
    Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
    Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
    Lee CL; Kuo HC
    Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
    Kuo HC
    Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Kuo HC; Jiang YH; Tsai YC; Kuo YC
    Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
    Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
    Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.